Company profile
Anavo Therapeutics BV
UNLOCKING THE PHOSPHATASE TARGET CLASS
- Industry
- Biotechnology Research
- Employees
- 26
- Headquarters
- Leiden, South Holland
- LinkedIn followers
- 2,053
- Office locations
- 1
Anavo Therapeutics BV company summary
Anavo Therapeutics BV is a company in the Biotechnology Research industry, headquartered in Leiden, South Holland. On LinkedIn the company has around 26 employees and 2,053 followers. Its listed specialties include drug discovery, phospatase biology, oncology.
What technology does Anavo Therapeutics BV use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Anavo Therapeutics BV
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.
Specialties
Where is Anavo Therapeutics BV located?
Anavo Therapeutics BV lists 1 location.
Compare companies similar to Anavo Therapeutics BV
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Anavo Therapeutics BV anavotx.com | Biotechnology Research | 26 | - | Leiden, South Holland |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Anavo Therapeutics BV
What does Anavo Therapeutics BV do?
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.
How many employees does Anavo Therapeutics BV have?
Anavo Therapeutics BV has around 26 employees on LinkedIn.
Where is Anavo Therapeutics BV headquartered?
Anavo Therapeutics BV is headquartered in Leiden, South Holland.
Build a lead list from companies like Anavo Therapeutics BV
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.